Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of Ionsys and Routine Care With Morphine IV (Intravenous) PCA in the Management of Early Post-Operative Mobilisation, Ability to Mobilise and in Time to Fitness For Discharge.

Next Previous
Trial Profile

Comparison of Ionsys and Routine Care With Morphine IV (Intravenous) PCA in the Management of Early Post-Operative Mobilisation, Ability to Mobilise and in Time to Fitness For Discharge.

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fentanyl (Primary) ; Morphine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms IMPACT
  • Sponsors Janssen-Cilag

Most Recent Events

  • 30 Dec 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
  • 15 Jul 2009 Actual number of patients (108) added as reported by ClinicalTrials.gov.
  • 10 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top